Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.
Gibori H, Eliyahu S, Krivitsky A, Ben-Shushan D, Epshtein Y, Tiram G, Blau R, Ofek P, Lee JS, Ruppin E, Landsman L, Barshack I, Golan T, Merquiol E, Blum G, Satchi-Fainaro R. Gibori H, et al. Among authors: ben shushan d. Nat Commun. 2018 Jan 2;9(1):16. doi: 10.1038/s41467-017-02283-9. Nat Commun. 2018. PMID: 29295989 Free PMC article.
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.
Yeini E, Ofek P, Pozzi S, Albeck N, Ben-Shushan D, Tiram G, Golan S, Kleiner R, Sheinin R, Israeli Dangoor S, Reich-Zeliger S, Grossman R, Ram Z, Brem H, Hyde TM, Magod P, Friedmann-Morvinski D, Madi A, Satchi-Fainaro R. Yeini E, et al. Among authors: ben shushan d. Nat Commun. 2021 Mar 26;12(1):1912. doi: 10.1038/s41467-021-22186-0. Nat Commun. 2021. PMID: 33771989 Free PMC article.
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.
Ferber S, Tiram G, Sousa-Herves A, Eldar-Boock A, Krivitsky A, Scomparin A, Yeini E, Ofek P, Ben-Shushan D, Vossen LI, Licha K, Grossman R, Ram Z, Henkin J, Ruppin E, Auslander N, Haag R, Calderón M, Satchi-Fainaro R. Ferber S, et al. Among authors: ben shushan d. Elife. 2017 Oct 4;6:e25281. doi: 10.7554/eLife.25281. Elife. 2017. PMID: 28976305 Free PMC article.
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.
Tiram G, Ferber S, Ofek P, Eldar-Boock A, Ben-Shushan D, Yeini E, Krivitsky A, Blatt R, Almog N, Henkin J, Amsalem O, Yavin E, Cohen G, Lazarovici P, Lee JS, Ruppin E, Milyavsky M, Grossman R, Ram Z, Calderón M, Haag R, Satchi-Fainaro R. Tiram G, et al. Among authors: ben shushan d. FASEB J. 2018 Jun 1:fj201701568R. doi: 10.1096/fj.201701568R. Online ahead of print. FASEB J. 2018. PMID: 29856660
Polyglutamate-based nanoconjugates for image-guided surgery and post-operative melanoma metastases prevention.
Epshtein Y, Blau R, Pisarevsky E, Koshrovski-Michael S, Ben-Shushan D, Pozzi S, Shenbach-Koltin G, Fridrich L, Buzhor M, Krivitsky A, Dey P, Satchi-Fainaro R. Epshtein Y, et al. Among authors: ben shushan d. Theranostics. 2022 Aug 29;12(14):6339-6362. doi: 10.7150/thno.72941. eCollection 2022. Theranostics. 2022. PMID: 36168618 Free PMC article.
Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins.
Blau R, Epshtein Y, Pisarevsky E, Tiram G, Israeli Dangoor S, Yeini E, Krivitsky A, Eldar-Boock A, Ben-Shushan D, Gibori H, Scomparin A, Green O, Ben-Nun Y, Merquiol E, Doron H, Blum G, Erez N, Grossman R, Ram Z, Shabat D, Satchi-Fainaro R. Blau R, et al. Among authors: ben shushan d. Theranostics. 2018 May 24;8(13):3437-3460. doi: 10.7150/thno.23853. eCollection 2018. Theranostics. 2018. PMID: 30026858 Free PMC article.
Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma.
Pisarevsky E, Blau R, Epshtein Y, Ben-Shushan D, Eldar-Boock A, Tiram G, Koshrovski-Michael S, Scomparin A, Pozzi S, Krivitsky A, Shenbach-Koltin G, Yeini E, Fridrich L, White R, Satchi-Fainaro R. Pisarevsky E, et al. Among authors: ben shushan d. Adv Ther (Weinh). 2020 Aug;3(8):2000028. doi: 10.1002/adtp.202000028. Epub 2020 May 12. Adv Ther (Weinh). 2020. PMID: 35754977 Free PMC article.
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.
Pozzi S, Scomparin A, Ben-Shushan D, Yeini E, Ofek P, Nahmad AD, Soffer S, Ionescu A, Ruggiero A, Barzel A, Brem H, Hyde TM, Barshack I, Sinha S, Ruppin E, Weiss T, Madi A, Perlson E, Slutsky I, Florindo HF, Satchi-Fainaro R. Pozzi S, et al. Among authors: ben shushan d. JCI Insight. 2022 Sep 8;7(17):e154804. doi: 10.1172/jci.insight.154804. JCI Insight. 2022. PMID: 35980743 Free PMC article.
25 results